WinstonWınston
Back
InMode logo

InMode

INMD
55
Medical - Devices · Healthcare
Price
$15.06
+0.14 (+0.94%)
Market Cap
$865.7M
Exchange
NASDAQ
Winston Score
55
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Good
Growth
Weak
Cash Flow
Exceptional
Stability
Good
Valuation
Good

Share count falling — buybacks

23.9% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 86.0M (2021) → 65.4M (2025)

Winston Score History

The full picture

InMode is a medical device company that makes machines used by doctors to perform cosmetic and surgical procedures. Its devices use radiofrequency energy to tighten skin, reduce fat, and treat other body concerns without major surgery. The main customers are plastic surgeons, dermatologists, and other medical professionals who offer these treatments to patients.

InMode makes money by selling its platforms to clinics and then earning additional revenue from consumables — single-use tips and accessories that doctors must buy to keep using the machines. The company is based in Israel but generates most of its revenue in the United States, which is a highly competitive cosmetic procedure market. With a gross margin above 75%, the business is efficient, but it faces real risk from slowing demand for elective cosmetic procedures, which tend to drop when consumers feel financially stressed. Competition from other energy-based device makers also puts pressure on pricing and market share.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
74.8%
Premium pricing power — 74.8% gross margin
Profit after running costs
Operating Margin
12.8%
Healthy — 12.8% operating margin
Return on the money invested
ROCE
11.0%
Below par — 11.0% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-6.7%
Shrinking sales (-6.7% YoY)
Profit growth
EPS YoY
-49.8%
Earnings shrinking (-49.8% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
114%
Turns 114% of profit into real cash
Spare cash per sale
FCF Margin
23.3%
Converts sales into free cash efficiently (23.3%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
100.00x
Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
12.0x
Attractive valuation — P/E 12.0

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year
P/E vs Forward
+0.8
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial